Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 12, 2009, Pages 1746-1752

  Kupczyk, M ^a   Antczak, A ^a   Kuprys Lipinska, I ^a   Kuna, P ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Aspirin sensitivity; Asthma; Lipoxins; Lys ASA; Nasal challenge

Indexed keywords

ACETYLSALICYLIC ACID; LEUKOTRIENE C4; LIPOXIN A; LYSINE; LYSINE ACETYLSALICYLATE; METHYLPREDNISOLONE; PLACEBO; SALBUTAMOL; ACETYLSALICYLIC ACID LYSINATE; ALLERGEN; DRUG DERIVATIVE; LIPOXIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BASOPHIL; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DRUG HYPERSENSITIVITY; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHIL COUNT; EPITHELIUM CELL; ERYTHEMA; FATTY ACID SYNTHESIS; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; HYPERSENSITIVITY; LUNG FUNCTION TEST; MALE; MONONUCLEAR CELL; NEUTROPHIL COUNT; NOSE MUCUS; NOSE SECRETION; POLYPECTOMY; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; THROAT IRRITATION; BIOSYNTHESIS; CASE CONTROL STUDY; DRUG TOLERANCE; IMMUNOLOGY; INFLAMMATION; METHODOLOGY; MIDDLE AGED; NOSE PROVOCATION TEST; POACEAE;

ADULT; ALLERGENS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; DRUG TOLERANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION; LEUKOTRIENE C4; LIPOXINS; LYSINE; MIDDLE AGED; NASAL PROVOCATION TESTS; POACEAE;

EID: 70449103037     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02047.x     Document Type: Article

References (28)

1. Bonnans C, Levy BD. Lipid mediators as agonists for the resolution of acute lung inflammation and injury. Am J Respir Cell Mol Biol 2007 36 : 201 205.
2. Bonnans C, Vachier I, Chavis C, Godarg P, Bousquet J, Chanez P. Lipoxins are potential endogenous anti-inflammatory mediators in asthma. Am J Respir Crit Care Med 2002 165 : 1531 1535.
3. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008 8 : 349 361.
4. 4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 2008 178 : 574 582.
5. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. Eur Respir J 2000 6 : 432 436.
6. Sanak M, Levy BD, Clish CB, Chiang N, Gronert K, Mastalerz L et al. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J 2000 16 : 44 49.
7. 4 generation: detection by a novel lipoxin A4-ELISA. Lipids 1993 28 : 1047 1053.
8. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007 62 : 1111 1118.
9. Picado C, Ramis I, Rosello J, Prat J, Bulbena O, Plaza V et al. Release of peptide leukotriene into nasal secretions after local instalation of aspirin in aspirin-sensitive patients. Am Rev Respir Dis 1992 145 : 65 69.
10. Milewski M, Mastalerz L, Niżankowska E, Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin sensitive asthma. J Allergy Clin Immunol 1998 101 : 581 586.
11. Greiff L, Meyer P, Svensson C, Persson CG, Andersson M. The "nasal pool"-device for challenge and lavage of the nasal mucosa in children: histamine-induced plasma exudation responses. Pediatr Allergy Immunol 1997 8 : 137 142.
12. Bousquet PJ, Combescure C, Neukirch F, Kloseek JM, Mechin H, Daures JP, Bousquet J. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007 62 : 367 372.
13. Haworth O, Levy BD. Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 2007 30 : 980 992.
14. Bonnans C, Chanez P, Chavis C. Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation? Allergy 2004 59 : 1027 1041.
15. Levy BD, Bonnans C, Silverman ES, Palmer LJ, Marigowda G, Israel E. Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 2005 172 : 824 830.
16. Christie PE, Spur BW, Lee TH, Scadding G. The effect of lipoxin A4 on airway responses in asthmatics subjects. Am Rev Respir Dis 1992 145 : 1281 1284.
17. Kupczyk M, Kupryś I, Górski P, Kuna P. Aspirin intolerance and allergy to house dust mites: important factors associated with the development of severe asthma. Ann Allergy Asthma Immunol 2004 92 : 453 458.
18. Kupczyk M, Kuprys I, Danilewicz M, Bochenska-Marciniak M, Murlewska M, Gorski P, Kuna P. Adhesion molecules and their ligands in nasal polyps of aspirin-hypersensitive patients. Ann Allergy Asthma Immunol 2006 96 : 105 111.
19. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 2005 73 : 141 162.
20. Claria J, Serhan CN. Aspirin triggers previously udescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 1995 92 : 9475 9479.
21. Chiang N, Serhan CN. New mechanism for an old drug. Aspirin triggers anti-inflammatory lipid mediators with gender implications. Comp Ther 2006 32 : 150 157.
22. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat 2002 68-69 : 433 455.
23. Schneider C, Brash AR. Stereospecificity of hydrogen abstraction in the conversion of arachidonic acid to 15R-HETE by aspirin treated cyclooxygenase-2. Implications for the alignment of substratein the active site. J Biol Chem 2000 275 : 4743 4746.
24. Picado C, Fernandez-Morata JC, Juan M, Roca-Ferrer J, Fuentes M, Xaubet A et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999 104 : 721 732.
25. Kowalski ML, Kowalewski M, Pawliczak R, Woszczek G, Grzegorczyk J. Human nasal ECs cultured from nasal polyps express both ceclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) mRNA. Eur Respir J 1997 10 : 255s.
26. Kowalski ML, Ptasinska A, Bienkiewicz B, Pawliczak R, DuBuske L. Differential effects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients. J Allergy Clin Immunol 2003 112 : 505 512.
27. Kowalski ML, Pawliczak R, Wozniak J, Siuda K, Poniatowska M, Iwaszkiewicz J et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000 161 : 391 398.
28. Mastalerz L, Sanak M, Gawlewicz-Mroczka A, Gielicz A, Cmiel A, Szczeklik A. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Thorax 2008 63 : 27 34.